The pharmaceutical giant GSK is revolutionizing its global manufacturing and supply chain operations by implementing a “Physical AI” strategy. By partnering with Weights & Biases, the company has established a centralized “Registry of Truth” to manage thousands of machine learning models across a fragmented multi-vendor environment. This infrastructure supports digital twins that monitor biological processes in real-time and agentic systems that automate complex decision-making. These advancements allow GSK to transition from reactive reporting to proactive MLOps, ensuring rigorous quality control and traceability. Ultimately, this technological foundation is designed to increase production yields and safety as the company scales to serve billions of patients.
This podcast directly follows this blog/embedded YouTube video HERE
